News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
Next >
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
June 21, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
May 01, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Shockwave Medical
April 05, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
SWAV
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
April 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Expands Commitment to Advance Health Equity
April 03, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
April 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Ambrx
March 07, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
January 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
January 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
January 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 11, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 07, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
December 05, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.